CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $73,000 | +12.3% | 11,561 | -37.5% | 0.00% | – |
| Q3 2022 | $65,000 | -1.5% | 18,511 | -16.8% | 0.00% | – |
| Q2 2022 | $66,000 | -10.8% | 22,261 | -5.9% | 0.00% | – |
| Q1 2022 | $74,000 | -6.3% | 23,661 | +0.6% | 0.00% | – |
| Q4 2021 | $79,000 | -34.2% | 23,511 | -28.0% | 0.00% | – |
| Q3 2021 | $120,000 | -19.5% | 32,645 | -5.0% | 0.00% | – |
| Q2 2021 | $149,000 | -7.5% | 34,350 | -3.6% | 0.00% | – |
| Q1 2021 | $161,000 | -33.7% | 35,625 | -18.7% | 0.00% | – |
| Q4 2020 | $243,000 | +6.1% | 43,801 | +38.2% | 0.00% | – |
| Q3 2020 | $229,000 | +281.7% | 31,696 | +86.2% | 0.00% | – |
| Q2 2020 | $60,000 | -31.0% | 17,021 | +0.0% | 0.00% | – |
| Q3 2019 | $87,000 | -28.1% | 17,018 | +0.9% | 0.00% | – |
| Q2 2019 | $121,000 | -48.7% | 16,868 | -5.1% | 0.00% | – |
| Q1 2019 | $236,000 | +73.5% | 17,779 | +3.3% | 0.00% | – |
| Q4 2018 | $136,000 | -20.5% | 17,219 | +11.2% | 0.00% | – |
| Q3 2018 | $171,000 | -11.9% | 15,479 | +7.4% | 0.00% | – |
| Q2 2018 | $194,000 | -83.1% | 14,419 | -83.7% | 0.00% | -100.0% |
| Q1 2018 | $1,151,000 | -25.4% | 88,585 | -47.1% | 0.00% | 0.0% |
| Q4 2017 | $1,542,000 | +0.4% | 167,544 | -12.1% | 0.00% | 0.0% |
| Q3 2017 | $1,536,000 | – | 190,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |